Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 19, 2011
Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment
H Odabas, N Ozdemir, M Isik, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 26, 2013
Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients
U Y Arslan, I Turker, S Aksoy, et al.
European Review for Medical and Pharmacological Sciences
|
October 20, 2022
Neuroprotective effects of amantadine for experimental acute carbon monoxide poisoning
E N Zengin, S Kayır, G Doğan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 25, 2013
Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity
M A N Sendur, S Aksoy, S Yaman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 22, 2013
Multiple primary malignant neoplasms: multi-center results from Turkey
N A Babacan, S Aksoy, B Cetin, et al.
Journal of Surgical Oncology
|
January 29, 2000
Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
I Barişta, G Tekuzman, S Yalçin, et al.
European Journal of Haematology
|
August 1, 1997
Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma
A Kars, I Celik, E Kansu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 3, 2013
Breast cancer in octogenarian women: clinical characteristics and outcome
T Y Kuzan, E Koca, O Dizdar, et al.
British Journal of Cancer
|
February 24, 2005
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group
F Icli, H Akbulut, A Uner, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 19, 2011
Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment
H Odabas, N Ozdemir, M Isik, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 26, 2013
Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients
U Y Arslan, I Turker, S Aksoy, et al.
European Review for Medical and Pharmacological Sciences
|
October 20, 2022
Neuroprotective effects of amantadine for experimental acute carbon monoxide poisoning
E N Zengin, S Kayır, G Doğan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 25, 2013
Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity
M A N Sendur, S Aksoy, S Yaman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 22, 2013
Multiple primary malignant neoplasms: multi-center results from Turkey
N A Babacan, S Aksoy, B Cetin, et al.
Journal of Surgical Oncology
|
January 29, 2000
Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
I Barişta, G Tekuzman, S Yalçin, et al.
European Journal of Haematology
|
August 1, 1997
Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma
A Kars, I Celik, E Kansu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 3, 2013
Breast cancer in octogenarian women: clinical characteristics and outcome
T Y Kuzan, E Koca, O Dizdar, et al.
British Journal of Cancer
|
February 24, 2005
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group
F Icli, H Akbulut, A Uner, et al.
Page
of 4